TheStreet.com |
Eli Lilly Beats Estimates, but Shares Head Lower Amid Diabetes Concerns
TheStreet.com Eli Lilly Beats Estimates, but Shares Head Lower Amid Diabetes Concerns. BMO Capital Markets analyst Alex Arfaei says the fourth-quarter results show how dependent the drugmaker is on major diabetes assets 'and doesn't alleviate our concerns.' ByArmie ... UPDATE 3-Lilly beats estimates; shares fall on diabetes, animal health concerns |
from diabetes - Google News
Social Plugin